Search Results 851-860 of 16478 for monoclonal antibody

1. Phase II Single-arm Study of Tepotinib Combined with Cetuximab - Mayo Clinic

   ... antibody targeted therapy due to mesenchymal epithelial transition factor (MET) amplification. ... monoclonal antibody therapy (panitumumab or cetuximab) ...

2. A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) - Mayo Clinic

   ... monoclonal antibody drugs) or paclitaxel 7. Patients with contraindications to paclitaxel therapy 8. Patients with persistent, clinically significant ...

3. Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer - Mayo Clinic

   ... monoclonal antibody, small molecule pathway inhibitor). Treatment with systemic corticosteroid or immune-modulators ≤ 7 days prior to randomization ...

4. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   ... monoclonal antibody against LOXL2, in patients with IPF. Read More on PubMed. Additional contact information. Non-cancer trials contact form. Phone: 800-664 ...

5. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

   Prior severe infusion reaction to a monoclonal antibody. Severe, active co-morbidity, defined as follows: Significant history of uncontrolled cardiac ...

6. A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia - Mayo Clinic

   At least 14 days since prior monoclonal antibody therapy; No more than 1 prior autologous or allogeneic hematopoietic stem cell transplantation. No evidence ...

7. A Study of Atezolizumab Alone or Combined with Immunomodulatory Drug and/or Daratumumab in Multiple Myeloma Patients - Mayo Clinic

   Receipt of ≥ 2 prior lines of therapy and progressed on treatment with an anti-CD38 monoclonal antibody (Cohort D3). Receipt of ≥ 4 lines of prior therapy ...

8. Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma - Mayo Clinic

   No more than 3 prior regimens for large cell component (e.g., one induction and two salvage therapies); monoclonal antibody alone or involved field/involved ...

9. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

   * Monoclonal gammopathy of undetermined significance ... * Known allergies, hypersensitivity, or intolerance to corticosteroids, monoclonal antibodies ...

10. A Study to Assess the Effectiveness, Safety and Tolerability of Lu AF82422 in Patients with Multiple System Atrophy - Mayo Clinic

    - The participant has been treated with an anti-?-synuclein monoclonal antibody, mesenchymal stem cells or an inhibitor of ?-synuclein aggregation within ...